Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
arborpharma.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$34.8M

About Arbor Pharmaceuticals

Arbor Pharmaceuticals is a specialty pharmaceutical company currently focused on the cardiovascular, hospital and pediatric markets.On August 24th, 2021, Arbor Pharmaceuticals was acquired by Azurity Pharmaceuticals. Terms of the transaction were not disclosed.

Arbor Pharmaceuticals Headquarter Location

6 Concourse Parkway Suite 1800

Atlanta, Georgia, 30328,

United States

678-334-2420

Latest Arbor Pharmaceuticals News

Nov 25, 2021, 23:00 ET Glioblastoma Multiforme Treatment Market to grow by USD 1.41 billion | Evolving Opportunities with Amgen ...

Nov 26, 2021

| Evolving Opportunities with Amgen Inc. & Amneal Pharmaceuticals Inc. | 17000+ Technavio Reports News provided by Share this article Share this article NEW YORK, Nov. 25, 2021 /PRNewswire/ -- Technavio's latest offering, the  Glioblastoma Multiforme Treatment Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. The glioblastoma multiforme treatment market is expected to increase by USD 1.41 billion from 2021 to 2026 at a CAGR of 8.48%. 37% of the market's growth will originate from North America. The US and Canada are the key markets for glioblastoma multiforme treatment in the region. The favorable government initiatives will facilitate the glioblastoma multiforme treatment market growth in North America. Attractive Opportunities in Glioblastoma Multiforme Treatment Market by End-user and Geography - Forecast and Analysis 2022-2026 Market Dynamics Factors such as the increasing incidence of glioblastoma multiforme and the increasing geriatric population will drive the growth of the Glioblastoma Multiforme Treatment Market. However, adverse effects associated with treatments might hamper the market growth. Company Profiles The glioblastoma multiforme treatment market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The glioblastoma multiforme treatment market report provides complete insights on key vendors including Amgen Inc., Amneal Pharmaceuticals Inc., Angiochem Inc., Arbor Pharmaceuticals LLC, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Pfizer Inc., Sumitomo Dainippon Pharma Co. Ltd., and Sun Pharmaceutical Industries Ltd. Few Companies with Key Offerings Amgen Inc.- The company offers an injection solution namely AMGEVITA for glioblastoma multiforme treatment. Amneal Pharmaceuticals Inc. - The company offers injection solutions namely Acyclovir for glioblastoma multiforme treatment. Angiochem Inc. - The company offers Antibody-drug conjugates (ADCs) for glioblastoma multiforme treatment. Competitive Analysis The report includes the competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Market Segmentation By End-user, the market is classified into Hospitals, Clinics, and Ambulatory Surgical Centers. The glioblastoma multiforme treatment market share growth by the hospital segment has been significant. By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market. Related Reports- Liposomal Products Market  -The liposomal products market share should rise by USD 2.21 billion from 2021 to 2026 at a CAGR of 7.81%. Download a free sample now! GERD Market -The GERD market share should rise by USD 793.85 million between 2021 and 2025 at a CAGR of 3.01%. Download a free sample now! Glioblastoma Multiforme Treatment Market Scope Report Coverage Companies profiled Amgen Inc., Amneal Pharmaceuticals Inc.,  Angiochem Inc., Arbor Pharmaceuticals LLC, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Pfizer Inc., Sumitomo Dainippon Pharma Co. Ltd., and Sun Pharmaceutical Industries Ltd. Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Arbor Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Arbor Pharmaceuticals is included in 2 Expert Collections, including Biopharmaceuticals.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

S

Sleep Health & Wellness

796 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.

Arbor Pharmaceuticals Patents

Arbor Pharmaceuticals has filed 30 patents.

The 3 most popular patent topics include:

  • Prodrugs
  • Food additives
  • Calcium channel blockers
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/15/2018

10/5/2021

Transcription factors, Autoimmune diseases, Fatty acid esters, Dosage forms, Drug delivery devices

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/15/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/5/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Transcription factors, Autoimmune diseases, Fatty acid esters, Dosage forms, Drug delivery devices

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Arbor Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Arbor Pharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.